CYTR Stock | News | Quote | Stock Forum | Thursday, December

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$CYTR CytRx Corp. CYTR Company Overview 

CytRx Corp. CYTR Current Price and Quotes
Last Price 4.02
Previous Close 2.39 Open 3.90
Daily Range 4.38 - 3.45 52wk Range 3.65 - 1.80
Volume 31,829,492 Dividend N/A
Average Vol (3m) 632,517 Yield N/A

CYTR Stock Message Board http://investorshangout.com/search?q=CYTR&...mp;yt1=Go!

Last Updated: Thursday, December 12, 2013 01:49:14 AM

CytRx Corp. CYTR
Company Information

11726 San Vicente Boulevard
Suite 650
Los Angeles, CA 90049

Phone: (310) 826-5648

CytRx Corp. CYTR
Not Available

CytRx Corp. CYTR
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000799698
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Mission Investor Relations
3645 Marketplace Blvd.
Atlanta, GA, 30344
United States


CytRx Corp. CYTR
CYTR Security Details

Share Structure

Market Value1 $104,518,776 a/o Dec 11, 2013
Shares Outstanding 41,975,412 a/o Oct 29, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record Not Available
Security Notes

New Issue=11-86 6,000,000 shs in units (3 shs Com & 3 Class A Warr 11-9-91) at $6 per unit by D.H. Blair & Co., Inc.
Capital Change=Capital Change=shs decreased by 1 for 4 split. Ex-date=02/06/1996. Rec date=02/06/1996. Pay date=02/06/1996.
Capital Change=shs decreased by 1 for 7 split. Ex-date=05/16/2012.
Short Selling Data

Short Interest 3,265,454 (-3.06%)
Nov 30, 2010
Significant Failures to Deliver  No
Transfer Agent(s)

American Stock Transfer & Trust Company

CytRx Corp. CYTR Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 100 250 100 9,500
Cost of Revenue - - - -
Gross Profit 100 250 100 9,500
Operating Expenses

Research and Development 12,685 15,491 8,507 7,542
Sales, General and Admin. 8,353 7,317 8,236 9,128
Non-Recurring Items - - - -
Other 114 96 108 475
Operating Income (21,052) (22,654) (16,751) (7,645)
Income From Continuing Operations

Add'l Income/Expense Items 3,090 8,327 17,159 2,325
Earnings Before Interest and Tax (17,962) (14,327) 408 (5,319)
Interest Expense - - - -
Earnings Before Tax (17,962) (14,327) 408 (5,319)
Income Tax 2 98 - (519)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (17,964) (14,425) 408 (4,800)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (17,964) (14,425) 408 (4,800)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (17,964) (14,425) 408 (4,800)

CytRx Corp. CYTR Recent News

Dec 11, 2013 Bullish Stocks Radar: CytRx Corporation, Echo Therapeutics Inc, Advanced Micro Devices, Inc, Baidu Inc
Dec 11, 2013 CytRx Reports Highly Statistically Significant Positive Results from its Global Phase 2b Clinical Trial
Dec 10, 2013 CytRx to Hold Conference Call December 11, 2013 at 10:30 a.m. Eastern Time to Discuss Results of Global Phase 2b Clinical Trial with Aldoxorubicin versus Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas
Dec 4, 2013 CytRx Corporation to Present at the Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11th, 2013
Nov 26, 2013 CytRx to Present at the Sixth Annual LD MICRO "Main Event" Conference in Los Angeles on December 3, 2013
Nov 20, 2013 CytRx Initiates Phase 2 Clinical Trial with Aldoxorubicin in Patients with Unresectable Glioblastoma Multiforme (Brain Cancer)
Nov 7, 2013 MissionIR Releases Exclusive Audio Interview With CytRx Management
Oct 31, 2013 CytRx Reports Further Positive Interim Data from Global Phase 2b Clinical Trial with Aldoxorubicin versus Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas
Oct 29, 2013 CytRx Reports 2013 Third Quarter Financial Results
Oct 25, 2013 Hot Topic: Breast Cancer Awareness Month 2013

1
2
next >

CYTR CytRx Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CYTR&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CYTR/quote
Stock Chart http://www.otcmarkets.com/stock/CYTR/chart
Company Info http://www.otcmarkets.com/stock/CYTR/company-info
Recent News http://www.otcmarkets.com/stock/CYTR/news
Financials http://www.otcmarkets.com/stock/CYTR/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CYTR/filings
Short Sales http://www.otcmarkets.com/stock/CYTR/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CYTR/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CYTR/research
Summary http://finance.yahoo.com/q?s=CYTR
Historical Prices http://finance.yahoo.com/q/hp?s=CYTR+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CYTR
Basic Chart http://finance.yahoo.com/q/bc?s=CYTR+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CYTR+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CYTR+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CYTR+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CYTR+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CYTR+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CYTR+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CYTR+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CYTR+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CYTR+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CYTR
Balance Sheet http://finance.yahoo.com/q/bs?s=CYTR
Cash Flow http://finance.yahoo.com/q/cf?s=CYTR+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CYTR
Market Watch http://www.marketwatch.com/investing/stock/CYTR
Bloomberg http://www.bloomberg.com/quote/CYTR:US
Morningstar http://quotes.morningstar.com/stock/s?t=CYTR
Bussinessweek http://investing.businessweek.com/research/st...icker=CYTR
Barchart http://www.barchart.com/quotes/stocks/CYTR
OTC Short Report http://otcshortreport.com/index.php?index=CYTR
Investopedia http://www.investopedia.com/markets/stocks/CYTR/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 35

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
Flexible Packaging Market to Hit $384.32B by 2031

Updated Category News Views 22

Packaging's Flexible Future Alright, here's the skinny: you might want to adjust those portfolios if you're watching the materials sector, because the flexible packaging market ain't just loosening up—it's stretching out like never before. By 2031, we're talking about it raking in a solid $384.32 billion, climbing from $313.25 billion in 2026. That's a not-so-shabby...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 152

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Tammy Keller's Devotional Guides Living with Purpose

Updated Category News Views 77

Finding Meaning in the Dash of Life Life isn’t just bookended by birth and death; it’s the dash in between that counts. If you were sitting next to Tammy Keller right now, you’d probably hear that heartfelt truth straight from her. Her new work, "Your--Dash Devotional," rattles the soul by offering a profound look at making every moment intentional, vivid, and...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 223

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 126

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 145

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading
ELEGRP Makes Dyson Supersonic Global Voltage Ready

Updated Category News Views 51

Plugging Into the Future of Travel ELEGRP's latest move brings the Dyson Supersonic Travel hair dryer into the limelight, all decked out with global voltage compatibility. It's like the Swiss Army knife of hair dryers—one minute it’s working on 100V, next it’s flipping over to a juicy 240V, without breaking a sweat. The ALCI Difference: Safety Takes Center Stage...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 5

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
NVIDIA Faces Fraud Suit: Investors Called to Action

Updated Category News Views 18

NVIDIA and the Quest for Accountability Nothing screams chaos in the market louder than a securities fraud lawsuit hitting the headlines. Investors currently eyeballing NVIDIA Corporation (NASDAQ: NVDA) are in for a wild ride. Yep, you heard it right—NVIDIA is smack in the middle of a class action lawsuit. They're being accused of misleading the market about some shady...

Continue Reading

Top 5 Most Recently Viewed Articles

Fortune Brands' Strategic Moves for Growth and Innovation

Updated Category News Views 506

Fortune Brands Embraces Change for Future Growth Fortune Brands Innovations, Inc. (NYSE: FBIN), a leading innovation company committed to transforming spaces into havens, has announced pivotal changes aimed at enhancing its growth opportunities. These strategic moves reflect the company's dedication to innovation and efficiency as it positions itself for future success....

Continue Reading
Robert Webb's Insightful Stock Options Exercise at NHI

Updated Category News Views 97

Robert Webb Exercises Stock Options at National Health Investors Recently, an important SEC filing revealed that Robert Webb, a Board Member at National Health Investors (NHI), has exercised a significant number of stock options. Key Highlights: The latest Form 4 filing shows that Webb exercised stock options for 70,000 shares of NHI, amounting to a remarkable $1,585,550....

Continue Reading
Palantir Technologies Inc. Increases Investment in UK Defense

Updated Category News Views 271

Palantir Technologies Inc. Stock Update Recently, shares of Palantir Technologies Inc. (NASDAQ: PLTR) saw an increase of 1.58% in pre-market trading following the announcement of a substantial deal with the U.K. government. Strategic Investment in UK Defense This exciting new partnership involves Palantir committing up to £1.5 billion, equivalent to approximately $2...

Continue Reading
Investigation of Varonis Systems, Inc.: A Call to Investors

Updated Category News Views 165

Investigation into Varonis Systems, Inc. Edelson Lechtzin LLP, a well-respected national law firm, is actively investigating Varonis Systems, Inc. (NASDAQ: VRNS) due to potential violations of federal securities laws. This investigation arises from troubling allegations regarding the company's financial disclosures and communication with investors. Varonis Systems,...

Continue Reading
Error Notification on NAV Values in Wealth Invest Fund

Updated Category News Views 127

Error Notification Regarding NAV Values Nasdaq Copenhagen A/S Nikolaj Plads 6 1067 København K Important Information The latest update relates to incorrect NAV values published for the I&T Nordiske Aktier Large Cap division (ISIN: DK0061276656) of Investeringsforeningen Wealth Invest during a specific time frame. Details of the NAV Error This error occurred from 09:45 on...

Continue Reading